Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 10.11.2026 EDVY.LN IE000CPG9HG3   50,002.00 EUR   1,178,957.43   23.578  ...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 DCC Energy plc

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, t...
-

AdaCore and CMU Researchers Announce Collaboration around Formal Verification of Rust for High-Integrity Systems

NEW YORK--(BUSINESS WIRE)--AdaCore, a trusted provider of software development tools and technologies for safety-critical, high-integrity, and secure systems, announces a collaboration with CMU researchers working on Verus, an open-source tool for mathematically proving the correctness of Rust code. The collaboration brings together two thought leaders who share one conviction: for software where failure costs lives, money, or missions, testing is not enough; correctness must be proven. AdaCore...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 Bodycote plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 easyJet plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 Tate & Lyle plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis

PARSIPPANY, N.J.--(BUSINESS WIRE)--Cytopoint Plus is the first and only USDA-licensed next-generation mAb that provides 75 days of allergic itch relief in a single injection....
-

InTandem Capital Partners Named to Inc.’s 2026 Founder-Friendly Investors List

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners, LP (“InTandem”) has been named to Inc.’s 2026 Founder-Friendly Investors list, which recognizes private equity firms, venture capital firms, and lenders with demonstrated track records of supporting founder-led companies. This year’s list recognizes InTandem among 14 designated healthcare specialist firms across the private equity investment landscape. The prestigious Founder-Friendly Investors list celebrates the investors and firms that wo...
-

Faeth Therapeutics to Participate in Upcoming November Investor Conferences

AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference Wednesday, November 11, 2026 1x1 investor meetings Boston, MA Jefferies Global Healthcare Conference in London Tuesday, November 17, 2026 Presentation at 8:30...
-

Altius Announces Definitive Agreement to Acquire TNR Gold Corp.

ST. JOHN’S, Newfoundland and Labrador--(BUSINESS WIRE)--Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) (“Altius”) announces that it has entered into a definitive agreement (the “Agreement”) with TNR Gold Corp. (TSXV: TNR) (“TNR”), pursuant to which Altius will acquire all of the issued and outstanding common shares of TNR that it does not already own by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) (the “Transaction”). With this Transa...